Pharmacogenetics Testing Market Expands as Precision Psychiatry Gains Momentum "Executive Summary Pharmacogenetics Testing in Psychiatry/Depression Market :
CAGR Value
The global pharmacogenetics testing in psychiatry/depression market size was valued at USD 1.34 billion in 2024 and is expected to reach USD 2.97 billion by 2032, at a CAGR of 10.4% during the forecast period
This Pharmacogenetics Testing in Psychiatry/Depression...
Join our community to interact with posts!